Task: Answer the multiple-choice question.
Query: Which drug exhibits a -4.603% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] COCCn1nnnc1C(c1ccccc1OC)N1CCN(c2ccccc2)CC1.Cl
[b] CC(NC(=O)c1cc(-c2ccncc2)nc2ccc(Br)cc12)C1CCCO1
Answer: a. COCCn1nnnc1C(c1ccccc1OC)N1CCN(c2ccccc2)CC1.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCCn1nnnc1C(c1ccccc1OC)N1CCN(c2ccccc2)CC1.Cl
COCCn1nnnc1C(c1ccccc1OC)N1CCN(c2ccccc2)CC1.Cl
1-[[1-(2-methoxyethyl)tetrazol-5-yl]-(2-methoxyphenyl)methyl]-4-phenylpiperazine;hydrochloride